Synergy CHC Corp. (SNYRQ)

Name: Synergy CHC Corp. (SNYRQ) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Also trades as SNYR. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0001562733 · Nasdaq · Medicinal Chemicals & Botanical Products

Sector Manufacturing
Incorporated NV
Fiscal year ends around Dec 31

For the year ended 2025-12-31, Synergy CHC Corp. reported revenue of $30.38M. Revenue fell 12.8% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $27.70M.

Key ratios (year ended 2025-12-31)

66.8%

Gross margin

-27.8%

Operating margin

-40.6%

Net margin

-12.8%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31
Revenue	$27.70M	$30.38M	$34.83M	$42.78M	$29.36M	$33.82M	$35.60M	$34.84M	$13.46M	$9.2K	n/a
Cost of Revenue	$9.59M	$10.08M	$11.19M	$10.70M	$9.14M	$11.04M	$9.82M	$10.21M	$5.31M	$5.6K	n/a
Gross Profit	$18.11M	$20.30M	$23.64M	$32.08M	$20.22M	$22.79M	$25.78M	$24.64M	$8.15M	$3.5K	n/a
Operating Income	-$10.97M	-$8.46M	$5.80M	$10.81M	-$7.96M	-$4.92M	$1.82M	$2.93M	$486.0K	-$958.1K	n/a
Depreciation & Amortization	$133.3K	$133.3K	$133.3K	$33.3K	$1.21M	$1.82M	$1.49M	$1.17M	$608.0K	n/a	n/a
EBITDA	-$10.84M	-$8.33M	$5.93M	$10.84M	-$6.74M	-$3.10M	$3.32M	$4.10M	$1.09M	n/a	n/a
Net Income	-$15.79M	-$12.34M	$2.12M	$6.34M	-$9.21M	-$6.16M	$499.6K	-$796.2K	-$7.54M	-$960.1K	n/a
EPS (Diluted)	n/a	-$1.27	$0.28	$0.86	-$0.10	-$0.07	$0.01	n/a	n/a	n/a	n/a
Total Assets	$6.46M	$10.16M	$16.34M	$12.24M	$5.19M	$20.01M	$24.03M	$20.46M	$26.76M	$55.4K	$3.2K
Total Liabilities	$31.87M	$33.29M	$32.97M	$39.55M	$10.39M	$16.04M	$14.60M	$13.35M	$21.34M	$181.0K	n/a
Shareholders' Equity	-$25.41M	-$23.13M	-$16.63M	-$27.31M	-$5.20M	$3.97M	$9.43M	$7.11M	$5.42M	-$125.7K	-$12.8K
Cash & Equivalents	$292.1K	$2.62M	$687.9K	$632.5K	$1.22M	$459.7K	$1.96M	$2.52M	$3.64M	$338	$3.2K
Operating Cash Flow	-$3.81M	-$2.59M	-$4.80M	$421.7K	$2.95M	$1.30M	-$831.1K	$6.04M	-$644.3K	-$489.2K	n/a
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	$129.1K	$153.0K	$302.2K	$7.8K	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	$1.18M	-$984.1K	$5.74M	-$652.1K	n/a	n/a
Dividends Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$1.17M	n/a	n/a
Shares Outstanding	11.30M	11.30M	8.54M	7.37M	89.89M	89.86M	89.86M	88.76M	81.69M	62.10M	180.00M
Weighted Average Diluted Shares	n/a	9.72M	7.63M	7.37M	n/a	89.86M	89.24M	n/a	n/a	n/a	n/a
EPS (Basic)	n/a	-$1.27	$0.28	$0.86	-$0.10	-$0.07	$0.01	n/a	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView